-
Signature
-
/s/ Michael F. MacLean, Attorney-in-Fact
-
Stock symbol
-
RNA
-
Transactions as of
-
Aug 6, 2024
-
Transactions value $
-
-$1,179,102
-
Form type
-
4
-
Date filed
-
8/7/2024, 05:46 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RNA |
Common Stock |
Options Exercise |
$34.7K |
+28K |
+13.66% |
$1.24* |
233K |
Aug 6, 2024 |
Direct |
F1 |
| transaction |
RNA |
Common Stock |
Sale |
-$1.21M |
-28K |
-12.01% |
$43.35 |
205K |
Aug 6, 2024 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-28K |
-5.73% |
$0.00 |
461K |
Aug 6, 2024 |
Common Stock |
28K |
$1.24 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: